Home \|\| About KDR \|\| Weekly Feature Archive
Vaccinate 11-year-old girls against cervical cancer: U.S. panel CBC News June 29, 2006 Girls as young as 11 should be routinely vaccinated against a sexually transmitted virus, a U.S. government advisory panel recommended Thursday. Experts say the vaccine Gardasil, made by Merck & Co., should be given to children before they become sexually active. The vaccine protects against most types of human papilloma virus, or HPV, that cause cervical cancer and genital warts. The Advisory Committee on Immunization Practices voted 13-0 to recommend the vaccine for girls and women between 11 and 26 and for women who have had abnormal Pap smears, genital warts or certain other conditions. Two of the panel's members abstained from voting because they worked on Merck-funded research. Article Posted at www.KnowledgeDrivenRevolution.com Federal health officials usually accept the committee's recommendations, which affect insurance coverage for vaccinations. Earlier this month, the U.S. Food and Drug Administration licensed the vaccine for women aged nine to 26 years. Health Canada is also looking at approving the vaccine for use in Canada, where this year nearly 1,400 new cases of cervical cancer are expected and 390 women will die from the disease. Since the vaccine doesn't protect against all strains of HPV, experts say women would still need to get a Pap test to screen for the virus. Several speakers at a public comment session also called for immunization of boys, since HPV has been linked to a rare penile cancer. Merck said clinical trials on the vaccine's effectiveness in males should be done by 2008. About KDR \| \| Home \| \| Weekly Features Archive	Weekly Weekly Features Archive
In Depth What Is Wrong With Canada Recent 9-11 News Suppressed by the Media Aspartame: The Sweetest Killer The Number 1 Reason YOU became a Slave Knowledge Driven Look at Your Favourite Canadian Political Parties
Archive April May June 2006 28 29 30 31 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 01 Weekly Features 2006 2005 Read Today's Knowledge Driven News

Home || About KDR || Weekly Feature Archive

Vaccinate 11-year-old girls against cervical cancer: U.S. panel

CBC News
June 29, 2006

Health Girls as young as 11 should be routinely vaccinated against a sexually transmitted virus, a U.S. government advisory panel recommended Thursday.

Experts say the vaccine Gardasil, made by Merck & Co., should be given to children before they become sexually active.

The vaccine protects against most types of human papilloma virus, or HPV, that cause cervical cancer and genital warts.

The Advisory Committee on Immunization Practices voted 13-0 to recommend the vaccine for girls and women between 11 and 26 and for women who have had abnormal Pap smears, genital warts or certain other conditions.

Two of the panel's members abstained from voting because they worked on Merck-funded research.

Article Posted at www.KnowledgeDrivenRevolution.com

Federal health officials usually accept the committee's recommendations, which affect insurance coverage for vaccinations.

Earlier this month, the U.S. Food and Drug Administration licensed the vaccine for women aged nine to 26 years.

Health Canada is also looking at approving the vaccine for use in Canada, where this year nearly 1,400 new cases of cervical cancer are expected and 390 women will die from the disease.

Since the vaccine doesn't protect against all strains of HPV, experts say women would still need to get a Pap test to screen for the virus.

Several speakers at a public comment session also called for immunization of boys, since HPV has been linked to a rare penile cancer.

Merck said clinical trials on the vaccine's effectiveness in males should be done by 2008.

Maple Leaf Footer
About KDR | | Home | | Weekly Features Archive